Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

From 2 January 2023, Professor Peter Magill will lead the Medical Research Council Brain Network Dynamics Unit (MRC BNDU) at the University of Oxford.

Peter Magill

The MRC BNDU is one of the leading international research centres exploring neuronal dynamics in health and disease. The MRC BNDU at the University of Oxford aims to understand and exploit the moment-to-moment interactions between nerve cells that are critical for brain function, with a focus on brain circuits underlying movement and memory.

The unit's research spans clinical, experimental and computational neuroscience, as well as bioengineering, and works towards the collective goal of developing novel therapies for the correction of disturbed circuit interactions arising in disease.

Advance towards breakthrough interventions

Professor Magill commented:

'I am delighted to be appointed as Director of the MRC BNDU.

The MRC BNDU is a special community. The Unit is making unique contributions to the research and innovation ecosystem, stemming not only from the new knowledge and technologies it generates and shares but also by providing an outstanding environment for training, career development, and engaging the public with medical research.

I look forward to leading the MRC BNDU as we harness in-house expertise and our partnerships with wider academia and industry to advance towards breakthrough interventions that strategically interface with the brain for therapy in neurological and psychiatric disorders.'

About Professor Magill

Professor Magill has been an MRC Programme Leader since 2009, taking on the role of interim director for the MRC BDNU in January 2021. Professor Magill has led contiguous MRC-funded research programmes since 2009. He currently sits on both the MRC Neuroscience and Mental Health Board and the Training and Careers Group.

Professor Magill is internationally recognised for his research on the basal ganglia, a network of nerve cells lying deep within the brain that are important for purposeful actions. Peter's research contributions to improve understanding of basal ganglia has been of great value to improving understanding of wider brain circuitry function, particularly for patients with Parkinson's disease.

Professor Magill played a key role in the creation of the MRC BNDU, and was the unit's founding Deputy Director from 2015 until 2021. He then acted as Unit Interim Director, fostering sustained excellence and growth in the Unit's fundamental and translational research portfolios.

 

Read more on the Nuffield Department of Clinical Neurosciences website

Similar stories

COVID-19 increased public trust in science, new survey shows

A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.

Gero Miesenböck awarded 2023 Japan Prize

Congratulations to Professor Gero Miesenböck, Department of Physiology, Anatomy and Genetics (DPAG), who has been awarded the 2023 Japan Prize in the field of Life Sciences, together with Professor Karl Deisseroth, for pioneering work in the field of optogenetics.

Major funding for Oxford will help find new cancer treatments

Cancer Research UK and the National Institute for Health and Care Research are investing over £3 million across the next five years into The University of Oxford’s Experimental Cancer Medicine Centre (ECMC). The investment will enable Oxford to expand its portfolio of precision prevention and early detection cancer trials.

Daniel Freeman to join Department of Experimental Psychology as Professor of Psychology

The Department of Experimental Psychology are delighted to announce that Daniel Freeman has been appointed as their new Professor of Psychology, joining from the Department of Psychiatry.

New study reveals role of lymphatic system in bone healing

It was previously assumed that bones lacked lymphatic vessels, but new research from the MRC Human Immunology Unit at Oxford's MRC Weatherall Institute for Molecular Medicine not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.

Vaccination shown to protect against pregnancy complications from COVID-19 Omicron variant

The global network led by the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford has today published, in The Lancet, the results of the ‘2022 INTERCOVID Study’ conducted in 41 hospitals across 18 countries.